[1]
Hrynkiv , Y. and Boiko , T. 2026. Cost of migraine attack control: comparative characteristics of rizatriptan preparations on the pharmaceutical market of Ukraine. Annals of Mechnikov’s Institute. 2 (Jun. 2026), 97–103. DOI:https://doi.org/10.37321/AMI.2026.2-97-103.